A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity

Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, Haajira Kaldine, Frances Ayres, Zanele Makhado, Mathilda Mennen, Sango Skelem, Noleen Williams, Nancy J. Sullivan, John Misasi, Glenda G. Gray, Linda-Gail Bekker, Veronica Ueckermann, Theresa M. Rossouw, Michael T. Boswell, Ntobeko A. B. Ntusi, Wendy A. Burgers, Penny L. Moore
doi: https://doi.org/10.1101/2021.11.05.21265853

Article Information

doi 
https://doi.org/10.1101/2021.11.05.21265853
History 
  • November 5, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Simone I. Richardson1,2,
  2. Nelia P. Manamela1,2,
  3. Boitumelo M. Motsoeneng1,2,
  4. Haajira Kaldine1,2,
  5. Frances Ayres1,2,
  6. Zanele Makhado1,2,
  7. Mathilda Mennen9,
  8. Sango Skelem9,
  9. Noleen Williams9,
  10. Nancy J. Sullivan3,
  11. John Misasi3,
  12. Glenda G. Gray4,
  13. Linda-Gail Bekker5,
  14. Veronica Ueckermann6,
  15. Theresa M. Rossouw7,
  16. Michael T. Boswell6,
  17. Ntobeko A. B. Ntusi8,9,10,12,
  18. Wendy A. Burgers8,11,12 and
  19. Penny L. Moore1,2,8,13,*
  1. 1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa
  2. 2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa
  3. 3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
  4. 4The South African Medical Research Council, Tygerberg, South Africa
  5. 5The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
  6. 6Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa
  7. 7Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
  8. 8Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
  9. 9Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
  10. 10Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
  11. 11Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa
  12. 12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa
  13. 13Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
  1. ↵*Corresponding author:
    Penny L. Moore, email: pennym{at}nicd.ac.za
Back to top
Posted November 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity
Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, Haajira Kaldine, Frances Ayres, Zanele Makhado, Mathilda Mennen, Sango Skelem, Noleen Williams, Nancy J. Sullivan, John Misasi, Glenda G. Gray, Linda-Gail Bekker, Veronica Ueckermann, Theresa M. Rossouw, Michael T. Boswell, Ntobeko A. B. Ntusi, Wendy A. Burgers, Penny L. Moore
medRxiv 2021.11.05.21265853; doi: https://doi.org/10.1101/2021.11.05.21265853
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area